Financial Statements and Related Announcement::Third Quarter Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
20-Feb-2019 15:47:09
Status
New
Announcement Sub Title
Third Quarter Results
Announcement Reference
SG190220OTHRHG7O
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Sub: Outcome of the Board Meeting February 14, 2019

We wish to inform you that Board at its meeting had approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2018.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These results are available on the website of the Company at www.glenmarkpharma.com.

Additional Details

For Financial Period Ended
31/12/2018

Attachments

SGX_BM_RESULT_14022019.pdf
Total size =9581K